Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,68 USD | -5,62% | -6,67% | -16,83% |
Omzet 2024 * | 28,24 mln. 26,31 mln. | Omzet 2025 * | 31,81 mln. 29,64 mln. | Marktkapitalisatie | 41,25 mln. 38,43 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -68 mln. -63,35 mln. | Nettowinst (verlies) 2025 * | -85 mln. -79,19 mln. | EV/omzet 2024 * | 1,46 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,3 x |
K/w-verhouding 2024 * |
-0,67
x | K/w-verhouding 2025 * |
-0,58
x | Werknemers | 89 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 80,91% |
Recentste transcriptie over Aadi Bioscience, Inc.
1 dag | -5,62% | ||
1 week | -6,67% | ||
Lopende maand | -28,21% | ||
1 maand | -22,58% | ||
3 maanden | -2,89% | ||
6 maanden | -60,19% | ||
Lopend jaar | -16,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Lennon
CEO | Chief Executive Officer | 53 | 02-10-23 |
Scott Giacobello
DFI | Director of Finance/CFO | 54 | 28-11-21 |
Neil Desai
CHM | Chairman | 59 | 01-10-11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Anupam Dalal
BRD | Director/Board Member | 52 | 26-08-21 |
Caley Castelein
CHM | Chairman | 53 | 26-08-21 |
Director/Board Member | 52 | 26-08-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 9 M€ | +5,51% | - | |
0.00% | 147 M€ | +4,88% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 1,68 | -5,62% | 166 974 |
24-04-24 | 1,78 | -3,26% | 110 341 |
23-04-24 | 1,84 | -3,16% | 83 965 |
22-04-24 | 1,9 | +3,26% | 175 059 |
19-04-24 | 1,84 | +2,22% | 137 812 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,83% | 41,25 mln. | |
-4,66% | 87,53 mld. | |
+2,63% | 40,42 mld. | |
-21,76% | 29,48 mld. | |
+54,82% | 25,43 mld. | |
-14,78% | 15,59 mld. | |
-18,49% | 11,49 mld. | |
-15,61% | 11,1 mld. | |
-44,02% | 11,3 mld. | |
+4,42% | 8,75 mld. |